In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer.
In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer.
复制标题
DOI：
10.1016/j.yexmp.2014.04.013
复制
发表时间：
2014-08
影响因子：
3.6
通讯作者：
M. McCarthy;Gregory Auda;Suchi Agrawal;Amy N. Taylor;Zack Backstrom;D. Mondal;K. Moroz;S. Dash
中科院分区：
文献类型：
--
作者：
M. McCarthy;Gregory Auda;Suchi Agrawal;Amy N. Taylor;Zack Backstrom;D. Mondal;K. Moroz;S. Dash
